195 related articles for article (PubMed ID: 37324055)
1. Therapeutic Applications of Curcumin and Derivatives in Colorectal Cancer.
Lambring C; Varga K; Livingston K; Lorusso N; Dudhia A; Basha R
Onco Ther; 2022; 9(1):51-62. PubMed ID: 37324055
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and Derivatives in Nanoformulations with Therapeutic Potential on Colorectal Cancer.
Idoudi S; Bedhiafi T; Hijji YM; Billa N
AAPS PharmSciTech; 2022 Apr; 23(5):115. PubMed ID: 35441267
[TBL] [Abstract][Full Text] [Related]
3. High-Payload Buccal Delivery System of Amorphous Curcumin-Chitosan Nanoparticle Complex in Hydroxypropyl Methylcellulose and Starch Films.
Lim LM; Hadinoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502305
[TBL] [Abstract][Full Text] [Related]
4. Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.
Huang M; Zhai BT; Fan Y; Sun J; Shi YJ; Zhang XF; Zou JB; Wang JW; Guo DY
Int J Nanomedicine; 2023; 18():4275-4311. PubMed ID: 37534056
[TBL] [Abstract][Full Text] [Related]
5. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis.
Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H
Phytother Res; 2024 Jun; ():. PubMed ID: 38837315
[TBL] [Abstract][Full Text] [Related]
6. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
Hu Y; He Y; Ji J; Zheng S; Cheng Y
Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability of curcumin amorphous nanocomposite prepared by a green process using modified starch.
Chen C; Wang Z; Fu H; Yu G; Luo X; Zhu K
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132210. PubMed ID: 38729473
[TBL] [Abstract][Full Text] [Related]
8. Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan.
Idoudi S; Bedhiafi T; Sahir F; Hijji Y; Uddin S; Merhi M; Dermime S; Billa N
Int J Biol Macromol; 2023 Apr; 235():123827. PubMed ID: 36858085
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake.
Liu L; Yang S; Chen F; Cheng KW
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268597
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive-to-penetrating controllable peptosomes-in-microspheres co-loaded with anti-miR-31 oligonucleotide and Curcumin for targeted colorectal cancer therapy.
Zhao R; Du S; Liu Y; Lv C; Song Y; Chen X; Zhang B; Li D; Gao S; Cui W; Plikus MV; Hou X; Wu K; Liu Z; Liu Z; Cong Y; Li Y; Yu Z
Theranostics; 2020; 10(8):3594-3611. PubMed ID: 32206110
[No Abstract] [Full Text] [Related]
11. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharide-Zein Composite Nanoparticles for Enhancing Cellular Uptake and Oral Bioavailability of Curcumin: Characterization, Anti-colorectal Cancer Effect, and Pharmacokinetics.
Liu L; Yang S; Chen F; Cheng KW
Front Nutr; 2022; 9():846282. PubMed ID: 35308263
[TBL] [Abstract][Full Text] [Related]
13. Improvement of the bioavailability of curcumin by a supersaturatable self nanoemulsifying drug delivery system with incorporation of a hydrophilic polymer: in vitro and in vivo characterisation.
Chen XL; Liang XL; Zhao GW; Zeng QY; Dong W; Ou LQ; Zhang HN; Jiang QY; Liao ZG
J Pharm Pharmacol; 2021 Mar; 73(5):641-652. PubMed ID: 33772289
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats.
Wang L; Li W; Cheng D; Guo Y; Wu R; Yin R; Li S; Kuo HC; Hudlikar R; Yang H; Buckley B; Kong AN
J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):131-144. PubMed ID: 32020381
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells.
Li G; Fang S; Shao X; Li Y; Tong Q; Kong B; Chen L; Wang Y; Yang J; Yu H; Xie X; Zhang J
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572508
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.
Guo Y; Su ZY; Zhang C; Gaspar JM; Wang R; Hart RP; Verzi MP; Kong AN
Biochem Pharmacol; 2017 Jul; 135():22-34. PubMed ID: 28267439
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H
Drug Deliv; 2019 Dec; 26(1):1017-1026. PubMed ID: 31578087
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth.
Ambegaokar SS; Wu L; Alamshahi K; Lau J; Jazayeri L; Chan S; Khanna P; Hsieh E; Timiras PS
Neuro Endocrinol Lett; 2003 Dec; 24(6):469-73. PubMed ID: 15073579
[TBL] [Abstract][Full Text] [Related]
20. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
